PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

46,361 stories, page 735 of 773

Advanced search
🇯🇵Industryshionogi.comTier 1 · Company source

Long-term commitment to improving R&D to provide novel treatments for infectious diseases

Shionogi (IR News)Original source
🇯🇵Industryshionogi.comTier 1 · Company source

Combating challenge of AMR

Shionogi (IR News)Original source
🇯🇵Industryshionogi.comTier 1 · Company source

Background of addressing the problem of antimicrobial resistance (AMR)

Shionogi (IR News)Original source
🇯🇵Industryshionogi.comTier 1 · Company source

Address the problem of antimicrobial resistance (AMR)

Shionogi (IR News)Original source
🇯🇵Industryshionogi.comTier 1 · Company source

SHIONOGI Infectious Disease Weeks

Shionogi (IR News)Original source
🇯🇵Industryshionogi.comTier 1 · Company source

Message from Top Management

Shionogi (IR News)Original source
🇯🇵Industryshionogi.comTier 1 · Company source

Commitment to Tax Compliance

Shionogi (IR News)Original source
🇯🇵Industryshionogi.comTier 1 · Company source

Compliance Promotion Structure and Initiatives

Shionogi (IR News)Original source
🇯🇵Industryshionogi.comTier 1 · Company source

Ensuring High Ethical Standards and Transparency in Business Activities

Shionogi (IR News)Original source
🇯🇵Industryshionogi.comTier 1 · Company source

Basic Views and Guidelines on Corporate Governance

Shionogi (IR News)Original source
🌍Industryshinpoong.co.krTier 1 · Company source

Shinpoong Pharm.co.,LTd : Partner enquiry

Shinpoong PharmOriginal source
🌍Industryshinpoong.co.krTier 1 · Company source

Supply Agreement with EMI Pharm, Serbia for Medicurtain, Anti-adhesion Barrier

Shinpoong PharmOriginal source
🌍Industryshinpoong.co.krTier 1 · Company source

Shinpoong Pharm.co.,LTd : News

Shinpoong PharmOriginal source
🌍Industryshinpoong.co.krTier 1 · Company source

Shin Poong presents the feasibility of SP-8203 for acute ischemic stroke patients

Shinpoong PharmOriginal source
🌍Industryshinpoong.co.krTier 1 · Company source

Shin Poong lauches A new anti-Malaria drug in Kenya

Shinpoong PharmOriginal source
🌍Industryshinpoong.co.krTier 1 · Company source

PYRAMAX(Pyronaridie-Artesunate) added to WHO's Model List of Essential Medicines (EML)

Shinpoong PharmOriginal source
🌍Industryshinpoong.co.krTier 1 · Company source

Shinpoong Pharm.co.,LTd : Platform

Shinpoong PharmOriginal source
🌍Industryshinpoong.co.krTier 1 · Company source

Shinpoong Pharm.co.,LTd : Partnership

Shinpoong PharmOriginal source
🌍Industryshinpoong.co.krTier 1 · Company source

Shinpoong Pharm.co.,LTd : Pipeline

Shinpoong PharmOriginal source
🌍Industryshinpoong.co.krTier 1 · Company source

Shinpoong Pharm.co.,LTd : APIs & Products

Shinpoong PharmOriginal source
🇺🇸Industrysevenbridges.comTier 1 · Company source

ZS Associates and Seven Bridges Partner to Innovate Drug Research and Propel Precision Medicine - Seven Bridges

Seven BridgesOriginal source
🇺🇸Industrysevenbridges.comTier 1 · Company source

Velsera to Showcase Significantly Expanded Bioinformatics Capabilities at 2023 Bio-IT World Conference

Seven BridgesOriginal source
🇺🇸Industrysevenbridges.comTier 1 · Company source

Seven Bridges Wins the Gold Stevie® Award for Most Innovative Company in the 2020 International Business Awards® - Seven Bridges

Seven BridgesOriginal source
🇺🇸Industrysevenbridges.comTier 1 · Company source

Seven Bridges Unlocks Population-Scale Clinico-Genomic Data for Accelerated Drug Discovery With Commercial Launch of ARIA™

Seven BridgesOriginal source
🇺🇸Industrysevenbridges.comTier 1 · Company source

Seven Bridges Selected by Pfizer to Support Data Management Solution for Single-Cell RNA Sequencing Data

Seven BridgesOriginal source
🇺🇸Industrysevenbridges.comTier 1 · Company source

Seven Bridges Names David J. Ramos Chief Technology Officer - Seven Bridges

Seven BridgesOriginal source
🇺🇸Industrysevenbridges.comTier 1 · Company source

Seven Bridges Launches Unified Patient Network to Facilitate Clinical Research with Aim to Advance Precision Medicine and Improve Patient Care - Seven Bridges

Seven BridgesOriginal source
🇺🇸Industrysevenbridges.comTier 1 · Company source

Seven Bridges Launches the GRAFTM Population Solution - Seven Bridges

Seven BridgesOriginal source
🇺🇸Industrysevenbridges.comTier 1 · Company source

Seven Bridges GRAF Named #3 on The Scientist’s Top 10 Innovations List for 2020

Seven BridgesOriginal source
🇺🇸Industrysevenbridges.comTier 1 · Company source

Seven Bridges Expands Platform to Support Execution of Nextflow and WDL Workflows - Seven Bridges

Seven BridgesOriginal source
🇺🇸Industrysevenbridges.comTier 1 · Company source

Seven Bridges Earns 2021 Frost & Sullivan Global Enabling Technology Leadership Award - Seven Bridges

Seven BridgesOriginal source
🇺🇸Industrysevenbridges.comTier 1 · Company source

Seven Bridges Collaborates with University of São Paulo and Google Cloud to Build a Brazilian Reference Genome - Seven Bridges

Seven BridgesOriginal source
🇺🇸Industrysevenbridges.comTier 1 · Company source

Seven Bridges Appoints Viresh Patel as Senior Vice President of Marketing - Seven Bridges

Seven BridgesOriginal source
🇺🇸Industrysevenbridges.comTier 1 · Company source

Seven Bridges Announces Strategic Advisory Board Appointments - Seven Bridges

Seven BridgesOriginal source
🇺🇸Industrysevenbridges.comTier 1 · Company source

Seven Bridges Announces Research Demonstrating the Advantages of Tailored Pangenome References - Seven Bridges

Seven BridgesOriginal source
🇺🇸Industrysevenbridges.comTier 1 · Company source

Seven Bridges Announces Participation in NIH INCLUDE Project Data Coordinating Center - Seven Bridges

Seven BridgesOriginal source
🇺🇸Industrysevenbridges.comTier 1 · Company source

Seven Bridges Announces Initial Close of Series C Funding from New Strategic Investor to Accelerate Product Development and Commercial Growth - Seven Bridges

Seven BridgesOriginal source
🇺🇸Industrysevenbridges.comTier 1 · Company source

Seven Bridges and Scripps Research Selected to Develop Data Ecosystem for the National Institute of Allergy and Infectious Diseases - Seven Bridges

Seven BridgesOriginal source
🇺🇸Industrysevenbridges.comTier 1 · Company source

Seven Bridges Advances Workflow Automation Capabilities to Make Complex Multi-Omic Analysis More Accessible to Broader Mix of Users

Seven BridgesOriginal source
🇺🇸Industrysevenbridges.comTier 1 · Company source

New Company, Velsera, Represents Summa Equity's Vision to Improve Global Health Outcomes - Seven Bridges

Seven BridgesOriginal source
🇺🇸Industrysegmed.aiTier 1 · Company source

Segmed Secures Independent HIPAA Expert Determination Across Imaging and Clinical Data

SegmedOriginal source
🇺🇸Industrysegmed.aiTier 1 · Company source

Segmed Secures $10.4 Million Series A Funding, Led by iGan Partners and Advocate Health

SegmedOriginal source
🇺🇸Industrysegmed.aiTier 1 · Company source

Segmed’s RWiD integrated into Bayer platform to the development of AI-powered solution

SegmedOriginal source
🇺🇸Industrysegmed.aiTier 1 · Company source

Segmed Renews ISO/IEC 27001:2022 Certification, Strengthening Its Leadership in Secure Medical Data Innovation

SegmedOriginal source
🇺🇸Industrysegmed.aiTier 1 · Company source

Segmed Partners with Verily to Expand Access to Real-World Imaging Data

SegmedOriginal source
🇺🇸Industrysegmed.aiTier 1 · Company source

Segmed Partners with Nucs AI to Advance AI Validation for Precision Oncology and Theranostics

SegmedOriginal source
🇺🇸Industrysegmed.aiTier 1 · Company source

Segmed New Brand Identity and Openda Platform

SegmedOriginal source
🇺🇸Industrysegmed.aiTier 1 · Company source

Segmed Named Quarterfinalist in the 2026 Digital Health & AI Awards

SegmedOriginal source
🇺🇸Industrysegmed.aiTier 1 · Company source

Segmed Achieves ISO 27001:2013 Information Security Certification

SegmedOriginal source
🇺🇸Industrysegmed.aiTier 1 · Company source

RYVER.AI and SEGMED Partner to Develop a AI Model for Synthetic Medical Image Generation

SegmedOriginal source
🇺🇸Industrysegmed.aiTier 1 · Company source

Protege and Segmed Partner to Unlock Medical Imaging Data for AI/ML Development

SegmedOriginal source
🇺🇸Industrysegmed.aiTier 1 · Company source

MAPI Partners with Segmed to Transform Medical Data Into Clinical Impact

SegmedOriginal source
🇺🇸Industrysegmed.aiTier 1 · Company source

iMerit, Segmed, and Advocate Health Announce Free Annotated 3D Mammography Data Set to Advance AI Research in Breast Cancer Detection

SegmedOriginal source
🇺🇸Industrysegmed.aiTier 1 · Company source

Segmed Appoints David Gascoigne as CEO in Leadership Transition

SegmedOriginal source
🌍Researchsciencedirect.comTier 1 · Trial registry

Synbiotic to Attenuate Resorption of the Skeleton (STARS): Design and participant recruitment of a randomized, double-blind, placebo-controlled trial to test the efficacy of SBD111 medical food in older women

Contemporary Clinical TrialsOriginal source
🌍Researchsciencedirect.comTier 1 · Trial registry

Cardiopulmonary exercise testing-based high-intensity interval training delivered via synchronous telehealth for metabolic dysfunction-associated steatotic liver disease: protocol of the CPHIT-1 study

Contemporary Clinical TrialsOriginal source
🌍Researchsciencedirect.comTier 1 · Trial registry

Virtual reality for pain and anxiety management during painful procedures in hospitalized older patients: A randomized controlled trial

Contemporary Clinical TrialsOriginal source
🌍Researchsciencedirect.comTier 1 · Trial registry

Randomized controlled trial of acute ketamine versus midazolam for recurrence of suicidality in adolescents (TASK): Rationale, design, and baseline characteristics

Contemporary Clinical TrialsOriginal source
🌍Researchsciencedirect.comTier 1 · Trial registry

Breast cancer screening based on clinical breast examination performed by community health workers: study protocol for a randomized clinical trial - ITABERAÍ Project

Contemporary Clinical TrialsOriginal source
🌍Researchsciencedirect.comTier 1 · Trial registry

Contingency management plus deep transcranial magnetic stimulation for the treatment of cocaine use disorder: Protocol of a randomized controlled trial

Contemporary Clinical TrialsOriginal source